NEUROONE MEDICAL TECHNOLOGIES Corp filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-04-30. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Ronald McClurg, Chief Financial Officer
On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the "Company") of his intention to retire as the Company's Chief Financial Officer.
Find people with the same kind of experience as the Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES Corp, with the record behind each one.
Find candidates like Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES CorpNew leaders review vendors and budgets in their first months. Get an alert the next time NEUROONE MEDICAL TECHNOLOGIES Corp is in the news or changes leadership.
Get an alert when NEUROONE MEDICAL TECHNOLOGIES Corp changes leadershipTools for this story
Each opens in a new tab, filled in for NEUROONE MEDICAL TECHNOLOGIES Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.